Hyperhomocysteinemia as an independent risk factor for cardioembolic stroke in the Turkish population

Nida Tascilar1, Sureyya Ekem, Esra Aciman

  • 1Department of Neurology, Zonguldak Karaelmas University Medical Faculty, Kozlu/Zonguldak, Turkey.

Insights

High homocysteine levels are common in Turkish patients with atherosclerotic and cardioembolic stroke. However, hyperhomocysteinemia is an independent risk factor only for cardioembolic stroke.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Homocysteine, an amino acid intermediate, can cause vascular injury and atherosclerotic plaque instability.
  • Elevated homocysteine levels are linked to hyperlipidemia and lipoprotein(a), and inversely to HDL cholesterol.
  • Previous studies on homocysteine's association with stroke subtypes and risk factors show inconsistent results, potentially due to ethnic variations.

Purpose of the Study:

  • To investigate the role of serum homocysteine levels in Turkish patients with atherosclerotic stroke and cardioembolic stroke.
  • To determine if hyperhomocysteinemia is an independent risk factor for these stroke subtypes in the Turkish population.

Main Methods:

  • Serum homocysteine, lipoprotein(a), and traditional stroke risk factors (hypertension, diabetes, smoking) were measured.
  • 103 patients with large-vessel atherosclerotic stroke, 37 with cardioembolic stroke, and 37 controls were analyzed.
  • Statistical analysis included logistic regression and correlation tests.

Main Results:

  • Hypertension was a significant risk factor across all patient groups (p = 0.001).
  • Hyperhomocysteinemia (≥15.90 µmol/L) was more prevalent in both atherosclerotic (p=0.0435) and cardioembolic stroke patients (p=0.007).
  • Hyperhomocysteinemia emerged as an independent risk factor solely for cardioembolic stroke (p=0.023, OR: 5.745) and correlated positively with lipoprotein(a) in atherosclerotic stroke (r=0.227, p=0.035).

Conclusions:

  • Hyperhomocysteinemia is frequently observed in Turkish patients with both large-vessel atherosclerotic and cardioembolic stroke.
  • Elevated homocysteine is an independent risk factor specifically for cardioembolic stroke within this population.
  • The findings highlight the importance of considering homocysteine levels in stroke risk assessment, particularly for cardioembolic events.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...